Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion
Researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as 5−Helix, to block SARS-CoV-2 spike-mediated cell-cell fusion.
Source: news-medical.net